Loading clinical trials...
Loading clinical trials...
aPCC and Emicizumab Safety Study in Congenital Hemophilia A Patients With Inhibitors (SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis)
Conditions
Interventions
Emicizumab
FEIBA
+1 more
Locations
2
United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Start Date
March 1, 2026
Primary Completion Date
March 1, 2027
Completion Date
March 1, 2027
Last Updated
February 18, 2026
NCT06820515
NCT07226206
NCT05987449
NCT04645199
NCT06833983
NCT05935358
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions